Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jan 31, 2023 6:30pm
168 Views
Post# 35258147

RE:RE:RE:RE:RE:RE:RE:RE:RE:Cheap Valuation

RE:RE:RE:RE:RE:RE:RE:RE:RE:Cheap Valuation
gudisgood wrote:
porksniffer wrote:
curiousj wrote: I appreciate the devil's advocate role you play... would you disagree that this is already priced in by investors?

Also, what are you looking for to buy GUD? if you're not interested in buying, are you short GUD and what would make you positive?



This stock was driven to over $11 by investors relying on PAST performance of a LUCKY CEO. He even admitted he got lucky.

Now you and and everyone else on this board is trapped like a rat in some stock that sells old drugs tossed away by their creators. What is priced in is what is known today. The markets they sell to are unstable.

I, like you got trapped. But I sold out over a year ago for a bit more than current price, booked a loss and promptly doubled my money elsewhere. Liberating and profitable. You would be wise to do the same. Unlike Chianchin, I am not as polite; MugMod should be investigated for the pumping and frauds he's committed. I hope you are not being influenced by his pumping. He has been wrong for 10 years. While Chianchin and other bears have got it spot on. This is a loser stock, the CEO was already a billionaire and retired. His wealth does not depend on this stock. Your does. Let that sink in. 


Congratulations on promptly doubling your money!

I do appreciate opposing views. What I would appreciate even more is reasoning behind the negative opinions. Just pointing out the share price is essentially meaningless. How much money do you think Knight will generate, say, three, four, or five years from now? What's your estimation of a fair value for this company?

"Drugs tossed away by their creators"... yes, one of the company's strategies is to look for drugs that fit the portfolio and that current owners don't pay much attention to. "Tossed away" is not exactly what happened with Exelon.

"What is priced in is what is known today"... okay, so why buy any stock then? How do you find those stocks that promptly double your money if everything is priced in? Or is it just in the case GUD?

"The markets they sell to are unstable"... certainly there's some merit to this statement. However, LatAm and everything that comes with it is a part of the reason why GUD is there. They want to be the partner of choice in a challenging environment.

I would love for the share price to have performed better over the past couple of years. On the other hand, this game is not supposed to be easy. The plus side is every shareholder gets to own a higher share of the company via buybacks at these prices.




And ... 

Paladin found a home in Canada and Africa.
Paladin also sold one African company for a larger piece of a second African business.
How stable is Sub-Saharan Africa ?
Don't think Latam is anymore or any less stable from the perspective of a drug licensing company.

And ...

Fairly valued shares will not happen until this company is widely held - that's the way it is.
There is little demand from the outside.
60+ people control around 70% of the business.
That's just simply a fact of life.

So ... my comments are bang on ... these share move sideways until they don't anymore.

The other thing ... understand it and use it to your advantage in this game.

Some ... just didn't listen to that advice as it's likely the most important advice that they would ever get here.  The only other thing I really offended was ... Goodman will not get voted off the island.  I'm batting quite well if I do say so myself.  Not sure why anyone would be angry with that.

Before the end of 2023, I am really hoping to share some more important thoughts.  Connected or not connected to a stock price move - doesn't matter.  It's about figuring out where this company is going ... not how the market is going to react to the price.

Again ... 60+ people control about 70% of the company.  You do NOT have a wel functioning market here ... yet.

: )
<< Previous
Bullboard Posts
Next >>